Patents by Inventor Eugene B. Chang

Eugene B. Chang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12240890
    Abstract: Provided herein are compositions and methods for treating and/or preventing pathogenic fungal infection and for maintenance of microbiome commensalism. In particular, provided herein are compositions comprising modified peptide YY (PYY) peptides and therapeutic and/or prophylactic methods of use thereof.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: March 4, 2025
    Assignee: The University of Chicago
    Inventors: Eugene B. Chang, Joseph F. Pierre, Katharine A. Harris
  • Publication number: 20250036261
    Abstract: An electronic device displays a messaging interface that allows a participant in a message conversation to capture, send, and/or play media content. The media content includes images, video, and/or audio. The media content is captured, sent, and/or played based on the electronic device detecting one or more conditions.
    Type: Application
    Filed: October 16, 2024
    Publication date: January 30, 2025
    Inventors: Lawrence Y. YANG, Eugene M. BISTOLAS, Jae Woo CHANG, Imran CHAUDHRI, Richard R. DELLINGER, Joshua B. DICKENS, Megan M. FROST, Roberto GARCIA, Stephen O. LEMAY, Marcel VAN OS, Justin WOOD
  • Publication number: 20200062823
    Abstract: Provided herein are compositions and methods for treating and/or preventing pathogenic fungal infection and for maintenance of microbiome commensalism. In particular, provided herein are compositions comprising modified peptide YY (PYY) peptides and therapeutic and/or prophylactic methods of use thereof.
    Type: Application
    Filed: May 16, 2018
    Publication date: February 27, 2020
    Inventors: Eugene B. Chang, Joseph F. Pierre, Katharine A. Harris
  • Publication number: 20080206188
    Abstract: The present invention provides a system for delivering a wide range of chemical and biological therapeutics, including protein therapeutics, via transepithelial routes. The system comprises a high molecular weight polyethylene glycol-like (HMW PEG-like) compound for use with a therapeutic compound. Optionally, the system comprises a composition containing one or more HMW PEGlike compounds and one or more therapeutics, supplemented with a protective polymer such as dextran and/or essential pathogen nutrients such as L-glutamine. Administered alone, the HMW PEG-like compounds also provide therapeutic benefits. Also provided are methods for preventing or treating epithelial diseases, disorders, or conditions, such as an epithelium at risk of developing gut-derived sepsis attributable to an intestinal pathogen, as well as methods for monitoring the administration of HMW PEG-like compounds.
    Type: Application
    Filed: April 20, 2005
    Publication date: August 28, 2008
    Inventors: John C. Alverdy, Eugene B. Chang, Elaine O. Petrof